CDKN2AIPNL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.868760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.642000E-01
Normal-vs-Stage2
3.484400E-01
Normal-vs-Stage3
1.461590E-01
Normal-vs-Stage4
7.115200E-01
Stage1-vs-Stage2
2.682600E-01
Stage1-vs-Stage3
1.706150E-01
Stage1-vs-Stage4
5.336800E-01
Stage2-vs-Stage3
1.634210E-01
Stage2-vs-Stage4
4.934800E-01
Stage3-vs-Stage4
2.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.734000E-01
Normal-vs-AfricanAmerican
2.259700E-02
Normal-vs-Asian
7.520300E-02
Caucasian-vs-AfricanAmerican
2.790200E-02
Caucasian-vs-Asian
2.246400E-02
AfricanAmerican-vs-Asian
7.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.346200E-01
Normal-vs-Female
3.508000E-01
Male-vs-Female
8.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.549800E-01
Normal-vs-Age(41-60Yrs)
7.437200E-01
Normal-vs-Age(61-80Yrs)
7.923500E-02
Normal-vs-Age(81-100Yrs)
2.043600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.796400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.173200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.829600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.149970E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.928200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.525200E-01
Normal-vs-Daily Drinker
5.716400E-01
Normal-vs-Weekly Drinker
9.504400E-02
Normal-vs-Occasional Drinker
5.653600E-01
Normal-vs-Social Drinker
8.126200E-01
Non Drinker-vs-Daily Drinker
2.762800E-01
Non Drinker-vs-Weekly Drinker
5.683000E-01
Non Drinker-vs-Occasional Drinker
1.640030E-01
Non Drinker-vs-Social Drinker
6.444500E-02
Daily Drinker-vs-Weekly Drinker
1.337030E-01
Daily Drinker-vs-Occasional Drinker
4.314400E-01
Daily Drinker-vs-Social Drinker
5.636400E-01
Weekly Drinker-vs-Occasional Drinker
1.013160E-01
Weekly Drinker-vs-Social Drinker
2.871600E-02
Occasional Drinker-vs-Social Drinker
6.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.458200E-01
Normal-vs-Grade 2
1.280160E-01
Normal-vs-Grade 3
2.029400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.834100E-02
Grade 1-vs-Grade 3
3.872300E-02
Grade 1-vs-Grade 4
3.458200E-01
Grade 2-vs-Grade 3
6.971400E-01
Grade 2-vs-Grade 4
1.280160E-01
Grade 3-vs-Grade 4
2.029400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.705900E-02
Normal-vs-NonDiabetic
6.543400E-01
Diabetic-vs-NonDiabetic
1.955440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.928000E-01
Normal-vs-NoPancreatitis
3.074000E-01
Pancreatitis-vs-NoPancreatitis
8.576200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.225200E-01
Normal-vs-N1
3.594400E-01
N0-vs-N1
2.156200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.802200E-01
Normal-vs-TP53-NonMutant
7.383200E-01
TP53-Mutant-vs-TP53-NonMutant
4.806200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
